Results 41 to 50 of about 273,177 (229)

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019

open access: yesEmerging Infectious Diseases, 2022
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional ...
Yousra Kherabi   +7 more
doaj   +1 more source

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. [PDF]

open access: yes, 2011
BACKGROUND: Sudan is a large country with a diverse population and history of civil conflict. Poverty levels are high with a gross national income per capita of less than two thousand dollars.
Bottomley, Christian   +23 more
core   +2 more sources

MDR-TB data

open access: yes, 2019
This is the dataset for my MDR-TB ...
zhijie zhang (7141082)
core   +1 more source

Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. [PDF]

open access: yes, 2015
BACKGROUND: Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices.
David Moore   +23 more
core   +1 more source

MDR-TB TREATMENT UPDATE

open access: yesInternational Journal of Infectious Diseases, 2023
Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. Conventional therapy for RR-TB is more toxic, less effective, and much more costly than drug-susceptible TB.
openaire   +2 more sources

Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents

open access: yesFrontiers in Medicine, 2023
BackgroundThere are few studies on medical conditions associated with the development of drug-resistant TB.ObjectiveWe investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.Materials
Jinkyeong Park   +2 more
doaj   +1 more source

The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis

open access: yesAdvanced Science, EarlyView.
Corramycin, a myxobacterial natural product antibiotic, exhibits potent bactericidal activity against multidrug‐resistant Mycobacterium tuberculosis. The compound hijacks bacterial transporters such as BacA and OppABCD to enter the cell and inhibits DNA synthesis through a previously unrecognized mode of DNA gyrase poisoning, locking the enzyme in an ...
Franziska Fries   +25 more
wiley   +1 more source

Decisions in TB diagnosis among high-risk MDR-TB participants.

open access: yes, 2022
Decisions in TB diagnosis among high-risk MDR-TB participants.
Udomsak Silachamroon (6166172)   +5 more
core   +1 more source

PERBEDAAN KADAR TSH PADA PENDERITA TB PARU MDR SEBELUM dan SESUDAH MENDAPAT ETIONAMID DI POLI TB MDR RSUD Dr. SOETOMO SURABAYA [PDF]

open access: yes, 2017
Latar belakang: Kasus Multidrug Resistance Tuberculosis (TB MDR) jumlahnya yang semakin meningkat tiap tahunnya, dimana obat-obatan yang dipakai dalam terapi TB MDR khususnya para-aminosalisilat (PAS) atau etionamid (Etio) atau kombinasi keduanya ...
Latar belakang: Kasus Multidrug Resistance Tuberculosis (TB MDR)
core   +1 more source

One‐Step Immobilized Phage Depolymerase Coatings for Catheter‐Related Bloodstream Infections

open access: yesAdvanced Science, EarlyView.
Catheter‐related bloodstream infections (CRBSI) caused by drug‐resistant Gram‐negative bacteria remain a major clinical challenge. Here, a polydopamine‐assisted depolymerase coating degrades bacterial capsules and restores serum‐mediated killing, effectively suppressing biofilms and reducing bacterial burden in vitro, ex vivo, and in vivo, presenting a
Lingkai Dong   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy